Biotechnology VALUE FUND L P, Insider at ChemoCentryx, Inc. (CCXI), bought 325,635 shares at $6.09 ($1.9M) on 2013-09-13, disclosed to the SEC on 2013-09-13.
Open-market purchase of $1.9M CCXI by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.94 | 105,892 | $629K | 32.5% |
| 2 | $5.94 | 210,066 | $1.2M | 64.5% |
| 3 | $6.09 | 3,370 | $21K | 1.1% |
| 4 | $6.09 | 6,307 | $38K | 2.0% |
| Total | $5.94 avg | 325,635 | $1.9M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |